The future of fMRI
Recent articles
This series of essays explores new developments and challenges in human brain imaging.
To make a meaningful contribution to neuroscience, fMRI must break out of its silo
We need to develop research programs that link phenomena across levels, from genes and molecules to cells, circuits, networks and behavior.
To make a meaningful contribution to neuroscience, fMRI must break out of its silo
We need to develop research programs that link phenomena across levels, from genes and molecules to cells, circuits, networks and behavior.
New tools help make neuroimaging accessible to more researchers
A lack of programming experience can derail experimental aspirations. But custom software packages, web-based applications and video tutorials make functional MRI concepts easier to grasp.
New tools help make neuroimaging accessible to more researchers
A lack of programming experience can derail experimental aspirations. But custom software packages, web-based applications and video tutorials make functional MRI concepts easier to grasp.
Should we use the computational or the network approach to analyze functional brain-imaging data—why not both?
Emerging methods make it possible to combine the two tactics from opposite ends of the analytic spectrum, enabling scientists to have their cake and eat it too.
Should we use the computational or the network approach to analyze functional brain-imaging data—why not both?
Emerging methods make it possible to combine the two tactics from opposite ends of the analytic spectrum, enabling scientists to have their cake and eat it too.
To improve big data, we need small-scale human imaging studies
By insisting that every brain-behavior association study include hundreds or even thousands of participants, we risk stifling innovation. Smaller studies are essential to test new scanning paradigms.
To improve big data, we need small-scale human imaging studies
By insisting that every brain-behavior association study include hundreds or even thousands of participants, we risk stifling innovation. Smaller studies are essential to test new scanning paradigms.
To make fMRI more clinically useful, we need to really get BOLD
A better understanding of the blood oxygen level dependent, or BOLD, signal requires more support for multimodal imaging studies.
To make fMRI more clinically useful, we need to really get BOLD
A better understanding of the blood oxygen level dependent, or BOLD, signal requires more support for multimodal imaging studies.
Explore more from The Transmitter
Reporter’s notebook: Highlights from INSAR 2025
The annual meeting brought autism researchers, advocates and clinicians to Seattle to discuss the latest research, including attempts to define subgroups, a potential new CHD8 macaque model and life expectancy gaps.
Reporter’s notebook: Highlights from INSAR 2025
The annual meeting brought autism researchers, advocates and clinicians to Seattle to discuss the latest research, including attempts to define subgroups, a potential new CHD8 macaque model and life expectancy gaps.
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
‘We still exist’: How four neuroscience advocacy groups are navigating federal DEI funding cuts
Trainees from underrepresented backgrounds are losing pillars of support in the current funding climate. Grassroots mentorship organizations are stepping in to continue championing early-career researchers.
‘We still exist’: How four neuroscience advocacy groups are navigating federal DEI funding cuts
Trainees from underrepresented backgrounds are losing pillars of support in the current funding climate. Grassroots mentorship organizations are stepping in to continue championing early-career researchers.